The potential roles of sphingolipids in vascular smooth-muscle function

G. F. Nixon (Corresponding Author), F. A. Mathieson, I. Hunter

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Increasing experimental evidence has demonstrated that sphingolipids are likely to have an important regulatory function in the cardiovascular system. Two sphingolipids released from activated platelets, and therefore of particular relevance, are S1P (sphingosine 1-phosphate) and SPC (sphingosylphosphocholine). Both S1P and SPC can act as vasoconstrictors and may modulate VSMC (vascular smooth muscle cell) phenotype, as observed during the pathogenesis of vascular disease. Recent research has suggested that SPC may act as a pro-inflammatory mediator in VSMCs and, in some circumstances, may also contribute to the development of vascular disease.

Original languageEnglish
Pages (from-to)908-909
Number of pages2
JournalBiochemical Society Transactions
Volume35
Issue number5
DOIs
Publication statusPublished - 2007

Keywords

  • inflammation
  • sphingolipid
  • vascular disease
  • vascular smooth muscle cell (VSMC)
  • vasoconstriction
  • sphingosine-1-phosphate
  • receptors
  • sphingosylphosphorylcholine
  • CA2+

Cite this

The potential roles of sphingolipids in vascular smooth-muscle function. / Nixon, G. F. (Corresponding Author); Mathieson, F. A.; Hunter, I.

In: Biochemical Society Transactions, Vol. 35, No. 5, 2007, p. 908-909.

Research output: Contribution to journalArticle

Nixon, G. F. ; Mathieson, F. A. ; Hunter, I. / The potential roles of sphingolipids in vascular smooth-muscle function. In: Biochemical Society Transactions. 2007 ; Vol. 35, No. 5. pp. 908-909.
@article{f467382a3ab64e75b5661e61f8eca843,
title = "The potential roles of sphingolipids in vascular smooth-muscle function",
abstract = "Increasing experimental evidence has demonstrated that sphingolipids are likely to have an important regulatory function in the cardiovascular system. Two sphingolipids released from activated platelets, and therefore of particular relevance, are S1P (sphingosine 1-phosphate) and SPC (sphingosylphosphocholine). Both S1P and SPC can act as vasoconstrictors and may modulate VSMC (vascular smooth muscle cell) phenotype, as observed during the pathogenesis of vascular disease. Recent research has suggested that SPC may act as a pro-inflammatory mediator in VSMCs and, in some circumstances, may also contribute to the development of vascular disease.",
keywords = "inflammation, sphingolipid, vascular disease, vascular smooth muscle cell (VSMC), vasoconstriction, sphingosine-1-phosphate, receptors, sphingosylphosphorylcholine, CA2+",
author = "Nixon, {G. F.} and Mathieson, {F. A.} and I. Hunter",
year = "2007",
doi = "10.1042/BST0350908",
language = "English",
volume = "35",
pages = "908--909",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "5",

}

TY - JOUR

T1 - The potential roles of sphingolipids in vascular smooth-muscle function

AU - Nixon, G. F.

AU - Mathieson, F. A.

AU - Hunter, I.

PY - 2007

Y1 - 2007

N2 - Increasing experimental evidence has demonstrated that sphingolipids are likely to have an important regulatory function in the cardiovascular system. Two sphingolipids released from activated platelets, and therefore of particular relevance, are S1P (sphingosine 1-phosphate) and SPC (sphingosylphosphocholine). Both S1P and SPC can act as vasoconstrictors and may modulate VSMC (vascular smooth muscle cell) phenotype, as observed during the pathogenesis of vascular disease. Recent research has suggested that SPC may act as a pro-inflammatory mediator in VSMCs and, in some circumstances, may also contribute to the development of vascular disease.

AB - Increasing experimental evidence has demonstrated that sphingolipids are likely to have an important regulatory function in the cardiovascular system. Two sphingolipids released from activated platelets, and therefore of particular relevance, are S1P (sphingosine 1-phosphate) and SPC (sphingosylphosphocholine). Both S1P and SPC can act as vasoconstrictors and may modulate VSMC (vascular smooth muscle cell) phenotype, as observed during the pathogenesis of vascular disease. Recent research has suggested that SPC may act as a pro-inflammatory mediator in VSMCs and, in some circumstances, may also contribute to the development of vascular disease.

KW - inflammation

KW - sphingolipid

KW - vascular disease

KW - vascular smooth muscle cell (VSMC)

KW - vasoconstriction

KW - sphingosine-1-phosphate

KW - receptors

KW - sphingosylphosphorylcholine

KW - CA2+

U2 - 10.1042/BST0350908

DO - 10.1042/BST0350908

M3 - Article

VL - 35

SP - 908

EP - 909

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 5

ER -